Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: POL6326
Sponsor: Polyphor Ltd.